| scholarly article | Q13442814 |
| P50 | author | Sripathi Sureban | Q42628730 |
| Nathaniel Weygant | Q59695323 | ||
| Courtney W Houchen | Q92996693 | ||
| Kenneth J Vega | Q96584539 | ||
| Stan A Lightfoot | Q117263017 | ||
| Mohammad Madhoun | Q117263024 | ||
| P2093 | author name string | Stephen J Meltzer | |
| Rhonda Souza | |||
| Shrikant Anant | |||
| Randal May | |||
| Dongfeng Qu | |||
| Rama Ramanujam | |||
| Joshua Whorton | |||
| Alessandra Reed | |||
| P2860 | cites work | Radiofrequency ablation in Barrett's esophagus with dysplasia | Q28246453 |
| Cancer statistics, 2009 | Q29547625 | ||
| Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas | Q34085302 | ||
| Biomarkers in Barrett esophagus | Q34231569 | ||
| Prevalence of Barrett's esophagus in the general population: an endoscopic study | Q34475247 | ||
| Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma | Q34554095 | ||
| LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's esophagus? | Q34677521 | ||
| Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice | Q34720935 | ||
| DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism | Q34773102 | ||
| Human Barrett's adenocarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrow-derived cells after allogeneic stem cell transplant. | Q35084086 | ||
| A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. | Q35827411 | ||
| Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus | Q37176043 | ||
| Acid, bile, and CDX: the ABCs of making Barrett's metaplasia | Q37192028 | ||
| Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism | Q37416031 | ||
| Cellular origin of Barrett's metaplasia and oesophageal stem cells | Q37713797 | ||
| Dysfunctional transforming growth factor-β signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma | Q39595493 | ||
| Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers | Q42472925 | ||
| Screening for Barrett's esophagus in colonoscopy patients with and without heartburn | Q44184935 | ||
| Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study | Q46863563 | ||
| Clinical practice. Barrett's esophagus. | Q51764391 | ||
| Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE). | Q53754804 | ||
| Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma | Q58204833 | ||
| Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus | Q73585993 | ||
| Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus | Q81226171 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus | Q82293629 | ||
| Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma | Q84113292 | ||
| Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma | Q84202292 | ||
| P433 | issue | 4 | |
| P921 | main subject | adenocarcinoma | Q356033 |
| Barrett's esophagus | Q808892 | ||
| P304 | page(s) | 773-780 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | Journal of Gastroenterology and Hepatology | Q15764401 |
| P1476 | title | Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma | |
| P478 | volume | 27 |
| Q38970151 | APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases |
| Q58729590 | Analysis of the clinical significance of DCLK1 colorectal cancer using novel monoclonal antibodies against DCLK1 |
| Q90859385 | Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cells |
| Q54095240 | Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer. |
| Q36556299 | Barrett esophagus: what a mouse model can teach us about human disease |
| Q85901179 | Barrett oesophagus: lessons on its origins from the lesion itself |
| Q39909790 | Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer |
| Q64904903 | Columnar-Lined Esophagus Develops via Wound Repair in a Surgical Model of Reflux Esophagitis. |
| Q52730707 | DCLK1 Expression in Colorectal Polyps Increases with the Severity of Dysplasia. |
| Q34619321 | DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition |
| Q41843301 | DCLK1 immunoreactivity in colorectal neoplasia. |
| Q33788066 | DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma |
| Q54317604 | DCLK1 is detectable in plasma of patients with Barrett's esophagus and esophageal adenocarcinoma. |
| Q38752206 | DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer |
| Q41906889 | DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer |
| Q37618755 | Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells. |
| Q50904140 | Dclk1-expressing tuft cells: critical modulators of the intestinal niche? |
| Q41505619 | Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma |
| Q36767646 | Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line |
| Q36738871 | Doublecortin-like kinase 1 expression associates with breast cancer with neuroendocrine differentiation |
| Q92356396 | Doublecotin-Like Kinase 1 Increases Chemoresistance of Colorectal Cancer Cells through the Anti-Apoptosis Pathway |
| Q64932160 | Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer. |
| Q49181272 | Expression of doublecortin and CaM kinase-like-1 protein in serrated neoplasia of the colorectum |
| Q38940530 | Genomics of Esophageal Cancer and Biomarkers for Early Detection |
| Q92203595 | Glyco-conjugated bile acids drive the initial metaplastic gland formation from multi-layered glands through crypt-fission in a murine model |
| Q38799879 | Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma |
| Q53724691 | Lgr5High/DCLK1High phenotype is more common in early stage and intestinal subtypes of gastric carcinomas. |
| Q34401562 | Long-lived intestinal tuft cells serve as colon cancer-initiating cells |
| Q38368079 | Mechanisms of Barrett's oesophagus: intestinal differentiation, stem cells, and tissue models |
| Q34508850 | Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus |
| Q52661910 | Pancreatic DCLK1+ cells originate distinctly from PDX1+ progenitors and contribute to the initiation of intraductal papillary mucinous neoplasm in mice. |
| Q37020846 | Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells |
| Q53270273 | Structural alterations of the mucosa stroma in the Barrett's esophagus metaplasia-dysplasia-adenocarcinoma sequence. |
| Q37058165 | The RNA-Binding Protein Musashi1: A Major Player in Intestinal Epithelium Renewal and Colon Cancer Development |
| Q38940526 | Transcommitment: Paving the Way to Barrett's Metaplasia |
| Q54318784 | Translational research on Barrett's esophagus. |
Search more.